SCHEMBL6166206

SCHEMBL6166206

CC(Cc1nn(-c2ccccn2)c2c1C(=O)CC(C)(C)C2)CC(C)(C)C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 8/20 0.42
CCNA2 P20248 6/20 0.40
CDK2 P24941 6/20 0.40
CCNO P22674 1/20 0.40
CCNE1 P24864 1/20 0.40
CCNA1 P78396 1/20 0.40
HSP90AB1 P08238 1/20 0.38
ALDH1A1 P00352 4/20 0.38
KMT2A Q03164 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
LMNA P02545 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
HPGD P15428 1/20 0.36
MAPT P10636 1/20 0.36
THRB P10828 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6164703 0.88 OPRM1 (0.45) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6164280 0.86 OPRM1 (0.45) OPRM1HSP90AB1ALDH1A1KMT2ANPSR1
SCHEMBL6164396 0.84 ALDH1A1 (0.41) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6166197 0.82 CCNA2 (0.41) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6164838 0.82 CCNA2 (0.41) OPRM1CCNA2CDK2HSP90AB1ALDH1A1
SCHEMBL6164260 0.82 ALDH1A1 (0.39) CCNA2CDK2CCNOCCNE1CCNA1
SCHEMBL6167358 0.80 ALDH1A1 (0.57) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6771777 0.80 OPRM1 (0.46) OPRM1HSP90AB1ALDH1A1NPSR1LMNA
SCHEMBL6164595 0.80 CCNA2 (0.47) OPRM1CCNA2CDK2CCNOCCNE1
SCHEMBL6771450 0.80 OPRM1 (0.46) OPRM1HSP90AB1ALDH1A1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed